SODIUM POLYSTYRENE SULFONATE Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Polystyrene Sulfonate patents expire, and when can generic versions of Sodium Polystyrene Sulfonate launch?
Sodium Polystyrene Sulfonate is a drug marketed by Belcher, Chartwell Rx, Citrusphrma, Cmp Pharma Inc, Epic Pharma Llc, Nuvo Pharms Inc, Pai Holdings Pharm, Upsher Smith Labs, Ani Pharms, Hikma, Morton Grove, and Roxane. and is included in twelve NDAs.
The generic ingredient in SODIUM POLYSTYRENE SULFONATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Polystyrene Sulfonate
A generic version of SODIUM POLYSTYRENE SULFONATE was approved as sodium polystyrene sulfonate by CMP PHARMA INC on January 19th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM POLYSTYRENE SULFONATE?
- What are the global sales for SODIUM POLYSTYRENE SULFONATE?
- What is Average Wholesale Price for SODIUM POLYSTYRENE SULFONATE?
Summary for SODIUM POLYSTYRENE SULFONATE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 56 |
| Clinical Trials: | 7 |
| Drug Prices: | Drug price information for SODIUM POLYSTYRENE SULFONATE |
| DailyMed Link: | SODIUM POLYSTYRENE SULFONATE at DailyMed |
Recent Clinical Trials for SODIUM POLYSTYRENE SULFONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, Irvine | Phase 4 |
| Tris Pharma, Inc. | Phase 4 |
| Weill Medical College of Cornell University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM POLYSTYRENE SULFONATE
US Patents and Regulatory Information for SODIUM POLYSTYRENE SULFONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belcher | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 205727-001 | Feb 23, 2016 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nuvo Pharms Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071-001 | Nov 28, 2014 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cmp Pharma Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 089910-001 | Jan 19, 1989 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Morton Grove | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 088717-001 | Sep 11, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pai Holdings Pharm | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 088786-001 | Sep 11, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
